BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 38237984)

  • 1. Innate immune responses to SARS-CoV-2.
    Dawoodi S; Rizvi SAA; Zaidi AK
    Prog Mol Biol Transl Sci; 2024; 202():127-154. PubMed ID: 38237984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe Acute Respiratory Syndrome Coronavirus 2: The Role of the Main Components of the Innate Immune System.
    Anaeigoudari A; Mollaei HR; Arababadi MK; Nosratabadi R
    Inflammation; 2021 Dec; 44(6):2151-2169. PubMed ID: 34524614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The battle between host and SARS-CoV-2: Innate immunity and viral evasion strategies.
    Zhang S; Wang L; Cheng G
    Mol Ther; 2022 May; 30(5):1869-1884. PubMed ID: 35176485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Escape and Over-Activation of Innate Immune Responses by SARS-CoV-2: Two Faces of a Coin.
    Mattoo SU; Kim SJ; Ahn DG; Myoung J
    Viruses; 2022 Mar; 14(3):. PubMed ID: 35336937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 Variant Delta Potently Suppresses Innate Immune Response and Evades Interferon-Activated Antiviral Responses in Human Colon Epithelial Cells.
    Tandel D; Sah V; Singh NK; Potharaju PS; Gupta D; Shrivastava S; Sowpati DT; Harshan KH
    Microbiol Spectr; 2022 Oct; 10(5):e0160422. PubMed ID: 36073824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA Sensors as a Mechanism of Innate Immune Evasion among SARSCoV2, HIV and Nipah Viruses.
    Dixon DCK; Ratan C; Nair B; Mangalath S; Abraham R; Nath LR
    Curr Protein Pept Sci; 2021 Oct; 22(4):273-289. PubMed ID: 33749559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pattern-recognition receptors (PRRs) in SARS-CoV-2.
    Isazadeh A; Heris JA; Shahabi P; Mohammadinasab R; Shomali N; Nasiri H; Valedkarimi Z; Khosroshahi AJ; Hajazimian S; Akbari M; Sadeghvand S
    Life Sci; 2023 Sep; 329():121940. PubMed ID: 37451397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Host cell-intrinsic innate immune recognition of SARS-CoV-2.
    Madden EA; Diamond MS
    Curr Opin Virol; 2022 Feb; 52():30-38. PubMed ID: 34814102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of Viral Infections by Innate Immunity.
    Carty M; Guy C; Bowie AG
    Biochem Pharmacol; 2021 Jan; 183():114316. PubMed ID: 33152343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innate Immune Response and Inflammasome Activation During SARS-CoV-2 Infection.
    Islamuddin M; Mustfa SA; Ullah SNMN; Omer U; Kato K; Parveen S
    Inflammation; 2022 Oct; 45(5):1849-1863. PubMed ID: 35953688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 Evasion of the Interferon System: Can We Restore Its Effectiveness?
    Sacchi A; Giannessi F; Sabatini A; Percario ZA; Affabris E
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like Receptor Mediation in SARS-CoV-2: A Therapeutic Approach.
    Manan A; Pirzada RH; Haseeb M; Choi S
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innate immunity during SARS-CoV-2: evasion strategies and activation trigger hypoxia and vascular damage.
    Amor S; Fernández Blanco L; Baker D
    Clin Exp Immunol; 2020 Nov; 202(2):193-209. PubMed ID: 32978971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N7-Methylation of the Coronavirus RNA Cap Is Required for Maximal Virulence by Preventing Innate Immune Recognition.
    Pan R; Kindler E; Cao L; Zhou Y; Zhang Z; Liu Q; Ebert N; Züst R; Sun Y; Gorbalenya AE; Perlman S; Thiel V; Chen Y; Guo D
    mBio; 2022 Feb; 13(1):e0366221. PubMed ID: 35073761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural Killer Cells in SARS-CoV-2 Infection: Pathophysiology and Therapeutic Implications.
    Di Vito C; Calcaterra F; Coianiz N; Terzoli S; Voza A; Mikulak J; Della Bella S; Mavilio D
    Front Immunol; 2022; 13():888248. PubMed ID: 35844604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon Control of Human Coronavirus Infection and Viral Evasion: Mechanistic Insights and Implications for Antiviral Drug and Vaccine Development.
    Zhao X; Chen D; Li X; Griffith L; Chang J; An P; Guo JT
    J Mol Biol; 2022 Mar; 434(6):167438. PubMed ID: 34990653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innate Immune Responses and Pulmonary Diseases.
    Liu T; Liu S; Zhou X
    Adv Exp Med Biol; 2021; 1304():53-71. PubMed ID: 34019263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2-mediated evasion strategies for antiviral interferon pathways.
    Oh SJ; Shin OS
    J Microbiol; 2022 Mar; 60(3):290-299. PubMed ID: 35122601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interaction between SARS-CoV-2 and Host Innate Immunity].
    Duan XQ; Xie H; Chen LM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Jan; 53(1):1-6. PubMed ID: 35048592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanistic understanding of innate and adaptive immune responses in SARS-CoV-2 infection.
    Balkhi MY
    Mol Immunol; 2021 Jul; 135():268-275. PubMed ID: 33940513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.